drugset / Trial / NCT01242748
A Degarelix Trial in Patients With Prostate Cancer
Non-randomizedParallel-groupOpen-labelTreatment
Summary
A phase III extension trial comparing the efficacy and safety of degarelix 3 month depot with the established therapy Zoladex 3 month implant in patients with prostate cancer.
Timeline
- Start
- 2010-10
- Primary completion
- 2011-12
- Completion
- 2012-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Degarelix | Other / unclassified | 480 mg | Subcutaneous |
| Comparator | Goserelin | Other / unclassified | 10.8 mg | Subcutaneous |